论文部分内容阅读
脑活素是由奥地利依比威药厂生产的治疗脑功能紊乱新药。据厂家介绍,该药在我国各大医院临床上广泛应用,效果比较理想,迄今尚未发现用药后持久的不良反应或危及生命的病例。该药在本院应用1年多,疗效较好,近我院发生持久性药症1例,现报道如下,供临床上参考,以引起注意。 患者,男,28岁,宁乡城郊建筑工人。因头部外伤后出血疼痛2小时,伴短暂意识障碍10分钟,于1993年4月1日12点抬送入院,住院号2464。查体:
Cerebrolysin is a new drug for the treatment of brain disorders produced by the Austrian Ibba Pharmaceuticals. According to the manufacturer’s introduction, the drug is widely used clinically in major hospitals in our country and the effect is quite satisfactory. Up to now, no persistent adverse drug reactions or life-threatening cases have been found. The drug used in our hospital more than 1 year, better efficacy, nearly one case of persistent drug in our hospital, are reported below, for clinical reference to attract attention. Patient, male, 28 years old, Ningxiang suburban construction workers. Hemorrhage pain due to head trauma 2 hours, accompanied by transient disturbance of consciousness for 10 minutes, on April 1, 1993 at 12:00 on the hospital admission, hospital number 2464. Physical examination: